FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Peter Albers

Research Profile

Disorders

Concepts & Ideas

Procedures

Chemicals & Drugs

Biological Tumor Markers

Anatomy

Testis

Co-author Network

Publications

TOP 3
Jörg Ellinger; Peter Albers; Frank G E Perabo; Stefan C Müller; Alexander von Ruecker; Patrick J Bastian
CpG island hypermethylation of cell-free circulating serum DNA in patients with testicular cancer.
Jörg Ellinger; Peter Albers; Stefan C Müller; Alexander von Ruecker; Patrick J Bastian
Circulating mitochondrial DNA in the serum of patients with testicular germ cell cancer as a novel noninvasive diagnostic biomarker.
M Hartmann; Roswitha Siener; Susanne Krege; H Schmelz; K-P Dieckmann; Axel Heidenreich; P Kwasny; M Pechoel; J Lehmann; Sabine Kliesch; Kai Uwe Köhrmann; Rolf Fimmers; L Weissbach; Volker Loy; Christian Wittekind; Peter Albers
[Results of the randomised phase III study of the German Testicular Cancer Study Group. Retroperitoneal lymphadenectomy versus one cycle BEP as adjuvant therapy for non-seminomatous testicular tumours in clinical stage I].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Peter Albers (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Jörg Ellinger; Peter Albers; Frank G E Perabo; Stefan C Müller; Alexander von Ruecker; Patrick J Bastian
CpG island hypermethylation of cell-free circulating serum DNA in patients with testicular cancer.
The Journal of urology 2009;182(1):324-9.
2009: Jörg Ellinger; Peter Albers; Stefan C Müller; Alexander von Ruecker; Patrick J Bastian
Circulating mitochondrial DNA in the serum of patients with testicular germ cell cancer as a novel noninvasive diagnostic biomarker.
BJU international 2009;104(1):48-52.
2009: M Hartmann; Roswitha Siener; Susanne Krege; H Schmelz; K-P Dieckmann; Axel Heidenreich; P Kwasny; M Pechoel; J Lehmann; Sabine Kliesch; Kai Uwe Köhrmann; Rolf Fimmers; L Weissbach; Volker Loy; Christian Wittekind; Peter Albers
[Results of the randomised phase III study of the German Testicular Cancer Study Group. Retroperitoneal lymphadenectomy versus one cycle BEP as adjuvant therapy for non-seminomatous testicular tumours in clinical stage I].
Der Urologe. Ausg. A 2009;48(5):523-8.
2008: Peter Albers
Editorial comment on: Comparison of complications in three incontinent urinary diversions.
European urology 2008;54(4):832-3.
2008: Peter Albers; Roswitha Siener; Susanne Krege; Hans-Uwe Schmelz; Klaus-Peter Dieckmann; Axel Heidenreich; Peter Kwasny; Maik Pechoel; Jan Lehmann; Sabine Kliesch; Kai Uwe Köhrmann; Rolf Fimmers; Lothar Weissbach; Volker Loy; Christian Wittekind; Michael Hartmann
Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(18):2966-72.
2006: Susanne Krege; C Boergermann; R Baschek; A Hinke; Tobias Pottek; Sabine Kliesch; Klaus-Peter Dieckmann; Peter Albers; B Knutzen; Stefan Weinknecht; HJ Schmoll; Jörg Beyer; H Ruebben
Single agent carboplatin for CS IIA/B testicular seminoma. A phase II study of the German Testicular Cancer Study Group (GTCSG).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(2):276-80.
2006: Guido Fechner; Roswitha Siener; M Reimann; L Kobalz; Peter Albers
Randomised phase II trial of gemcitabine and paclitaxel second-line chemotherapy in patients with transitional cell carcinoma (AUO Trial AB 20/99).
International journal of clinical practice 2006;60(1):27-31.
2005: Ali Fuat Okuducu; Viktor Janzen; Yon Ko; Jens Claus Hahne; Hong Lu; Zhan-Lu Ma; Peter Albers; Aygun Sahin; Axel Wellmann; Peter Scheinert; Nicolas Wernert
Cellular retinoic acid-binding protein 2 is down-regulated in prostate cancer.
International journal of oncology 2005;27(5):1273-82.
2005: Guido Fechner; Frank Dederichs; Doris Schmidt; Stefan Müller; Peter Vaupel; Peter Albers
Hyperoxia-induced improvement of the in vitro response to gemcitabine in transitional cell carcinoma.
Anticancer research 2005;25(5):3413-8.
2005: Yon Ko; Tanja Hahn; Hong Lu; Zhan-Lu Ma; Jian Chen; Marcus Rothe; Alexandra Florin; Stefan Fronhoffs; Peter Albers; Agapios Sachinidis; Hans Vetter; Annette Kaminski; Peter Behrens; Axel Wellmann; Nicolas Wernert
A novel component of the ubiquitin pathway, ubiquitin carboxyl extension protein 1 is overexpressed in prostate cancer.
International journal of molecular medicine 2005;15(2):183-96.
2005: Matthias Port; Hans U Schmelz; M Stockinger; Christoph Sparwasser; Peter Albers; T Pottek; Michael Abend
Gene expression profiling in seminoma and nonseminoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(1):58-69.
2004: Patrick J Bastian; Peter Albers; Herbert Hanitzsch; Giancarlo Fabrizi; Romano Casadei; Axel Haferkamp; Stefan Schumacher; Stefan C Müller
Health-related quality-of-life following modified ureterosigmoidostomy (Mainz Pouch II) as continent urinary diversion.
European urology 2004;46(5):591-7.
2004: Patrick J Bastian; Peter Albers; Axel Haferkamp; Stefan Schumacher; Stefan C Müller
Modified ureterosigmoidostomy (Mainz Pouch II) in different age groups and with different techniques of ureteric implantation.
BJU international 2004;94(3):345-9.
2004: Patrick J Bastian; Dirk Skowasch; Gerhard Bauriedel; Peter Behrens; Stefan C Muller; Peter Albers
Primary extragonadal germ cell tumor of the prostate in a young man.
International journal of urology : official journal of the Japanese Urological Association 2004;11(8):671-3.
2004: Patrick J Bastian; Peter Albers; H Hanitzsch; G Fabrizi; R Casadei; Axel Haferkamp; Stefan Schumacher; Stefan C Müller
[The modified ureterosigmoidostomy (Mainz pouch II) as a continent form of urinary diversion].
Der Urologe. Ausg. A 2004;43(8):982-8.
2004: Peter Albers; Lothar Weissbach; Susanne Krege; Sabine Kliesch; Michael Hartmann; Axel Heidenreich; Peter Walz; Markus Kuczyk; Rolf Fimmers
Prediction of necrosis after chemotherapy of advanced germ cell tumors: results of a prospective multicenter trial of the German Testicular Cancer Study Group.
The Journal of urology 2004;171(5):1835-8.
2004: Peter Albers; Wolfgang Höltl; Axel Heidenreich; Seyedhossein Aharinejad
[Thoracoabdominal resection of retrocrural residual tumors].
Aktuelle Urologie 2004;35(2):141-50; quiz 151-2.
2004: Peter Albers
Resection of retroperitoneal residual tumor after chemotherapy for testicular cancer indication and surgical techniques.
Critical reviews in oncology/hematology 2004;50(1):79-85.
2004: Martin E Lipphardt; Peter Albers
Late relapse of testicular cancer.
World journal of urology 2004;22(1):47-54.
2004: Elisabeth Sievers; Peter Albers; Ingo G H Schmidt-Wolf; Angela Märten
Telomerase pulsed dendritic cells for immunotherapy for renal cell carcinoma.
The Journal of urology 2004;171(1):114-9.
2003: Frank G E Perabo; Heike Lindner; Doris Schmidt; Dirk Huebner; Johannes Blatter; Rolf Fimmers; Stefan C Müller; Peter Albers
Preclinical evaluation of gemcitabine/paclitaxel-interactions in human bladder cancer lines.
Anticancer research 2003;23(6C):4805-14.
2003: Patrick J Bastian; Axel Haferkamp; Peter Albers; Stefan C Müller
[Medizip surgical zipper: a new form of non-invasive wound closure with a surgical zipper].
Aktuelle Urologie 2003;34(6):398-401.
2003: Mirko Adam; Doris Schmidt; Eva Wardelmann; Nicolas Wernert; Peter Albers
Angiogenetic protooncogene ets-1 induced neovascularization is involved in the metastatic process of testicular germ cell tumors.
European urology 2003;44(3):329-36.
2003: Holger Palmedo; Agnieszka Manka-Waluch; Peter Albers; Ingo G H Schmidt-Wolf; Michael Reinhardt; Samer Ezziddin; Alexius Y Joe; Roland Roedel; Rolf Fimmers; Furn F Knapp; Stefan Guhlke; Hans-Jürgen Biersack
Repeated bone-targeted therapy for hormone-refractory prostate carcinoma: tandomized phase II trial with the new, high-energy radiopharmaceutical rhenium-188 hydroxyethylidenediphosphonate.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(15):2869-75.
2003: Peter Albers; Diethild Melchior; Stefan C Müller
Surgery in metastatic testicular cancer.
European urology 2003;44(2):233-44.
2003: Diethild Melchior; Stefan C Müller; Peter Albers
Extensive surgery in metastatic testicular cancer.
Aktuelle Urologie 2003;34(4):214-22.
2003: Patrick J Bastian; Axel Haferkamp; Peter Albers; Stefan C Müller
A new form of noninvasive wound closure with a surgical zipper.
The Journal of urology 2003;169(5):1785-6.
2003: Axel Heidenreich; Peter Albers; Michael Hartmann; Sabine Kliesch; Kai-Uwe Kohrmann; Susanne Krege; Philipp Lossin; Lothar Weissbach
Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group.
The Journal of urology 2003;169(5):1710-4.
2003: Peter Albers; Roswitha Siener; Sabine Kliesch; Lothar Weissbach; Susanne Krege; Christoph Sparwasser; Harald Schulze; Axel Heidenreich; Werner de Riese; Volker Loy; Erhard Bierhoff; Christian Wittekind; Rolf Fimmers; Michael Hartmann
Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: results of the German Testicular Cancer Study Group Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(8):1505-12.
2003: Susan Lo; Axel Alléra; Peter Albers; Jörg Heimbrecht; Eckard Jantzen; Dietrich Klingmüller; Stephan Steckelbroeck
Dithioerythritol (DTE) prevents inhibitory effects of triphenyltin (TPT) on the key enzymes of the human sex steroid hormone metabolism.
The Journal of steroid biochemistry and molecular biology 2003;84(5):569-76.
2003: Angela Märten; Sabine Renoth; Thomas Heinicke; Peter Albers; Andreas Pauli; Ulrich Mey; Reiner Caspari; Dimitri Flieger; Peter Hanfland; Alexander von Ruecker; Anna Maria Eis-Hübinger; Stefan Müller; Ingo Schwaner; Uwe Lohmann; Guido Heylmann; Tilman Sauerbruch; Ingo G H Schmidt-Wolf
Allogeneic dendritic cells fused with tumor cells: preclinical results and outcome of a clinical phase I/II trial in patients with metastatic renal cell carcinoma.
Human gene therapy 2003;14(5):483-94.
2003: Bjorn O Backhaus; Stefan C Muller; Peter Albers
Corporoplasty for advanced Peyronie's disease using venous and/or dermis patch grafting: new surgical technique and long-term patient satisfaction.
The Journal of urology 2003;169(3):981-4.
2003: Guido Fechner; Frank G E Perabo; Doris H Schmidt; L Haase; E Ludwig; Heinrich Schueller; Johannes Blatter; S C Mller; Peter Albers
Preclinical evaluation of a radiosensitizing effect of gemcitabine in p53 mutant and p53 wild type bladder cancer cells.
Urology 2003;61(2):468-73.
2003: Patrick J Bastian; Peter Albers
[Abnormalities of the urachus].
Aktuelle Urologie 2003;34(1):55-61.
2002: Angela Märten; Dimitri Flieger; Sabine Renoth; Silvia Weineck; Peter Albers; Markus Compes; Björn Schöttker; Carsten Ziske; Steffen Engelhart; Peter Hanfland; Ludmila Krizek; Cora Faber; Alexander von Ruecker; Stefan Müller; Tilman Sauerbruch; Ingo G H Schmidt-Wolf
Therapeutic vaccination against metastatic renal cell carcinoma by autologous dendritic cells: preclinical results and outcome of a first clinical phase I/II trial.
Cancer immunology, immunotherapy : CII 2002;51(11-12):637-44.
2002: Peter Albers
Surgery in testis cancer: laparoscopic and open techniques.
Current opinion in urology 2002;12(5):435-40.
2002: Peter Albers
[Diagnosis and therapy of testicular tumors].
Der Urologe. Ausg. A 2002;41(4):374-85; quiz 386-7.
2002: Axel Wellmann; Volker Wollscheid; Hong Lu; Zhan-Lu Ma; Peter Albers; Karin Schütze; Volker Rohde; Peter Behrens; Stephan Dreschers; Yon Ko; Nicolas Wernert
Analysis of microdissected prostate tissue with ProteinChip arrays--a way to new insights into carcinogenesis and to diagnostic tools.
International journal of molecular medicine 2002;9(4):341-7.
2002: Peter Albers; Roswitha Siener; M Härtlein; M Fallahi; D Haeutle; Frank G E Perabo; Gabriel Steiner; Johannes Blatter; Stefan C Müller
Gemcitabine monotherapy as second-line treatment in cisplatin-refractory transitional cell carcinoma - prognostic factors for response and improvement of quality of life.
Onkologie 2002;25(1):47-52.
2002: Frank G E Perabo; Gabriel Steiner; Peter Albers; Stefan C Müller
Treatment of penile strangulation caused by constricting devices.
Urology 2002;59(1):137.
2001: Axel Heidenreich; Lothar Weissbach; Wolfgang Höltl; Peter Albers; Sabine Kliesch; Kai Uwe Köhrmann; Klaus-Peter Dieckmann
Organ sparing surgery for malignant germ cell tumor of the testis.
The Journal of urology 2001;166(6):2161-5.
2001: Diethild Melchior; P Hammer; Rolf Fimmers; H Schüller; Peter Albers
Long term results and morbidity of paraaortic compared with paraaortic and iliac adjuvant radiation in clinical stage I seminoma.
Anticancer research 2001;21(4B):2989-93.
2001: Frank G E Perabo; S Kamp; D Schmidt; Heike Lindner; Gabriel Steiner; R H Mattes; Andreas Wirger; K Pegelow; Peter Albers; Elise C Kohn; Alexander von Ruecker; Stefan C Mueller
Bladder cancer cells acquire competent mechanisms to escape Fas-mediated apoptosis and immune surveillance in the course of malignant transformation.
British journal of cancer 2001;84(10):1330-8.
2001: Peter Albers; Frank G E Perabo; Diethild Melchior; Roswitha Siener
Adjuvant chemotherapy in stage I and stage II testicular cancer.
World journal of urology 2001;19(2):76-81.
2001: Burghardt Wittig; Angela Märten; Tomislav Dorbic; Silvia Weineck; H Min; S Niemitz; B Trojaneck; Dimitri Flieger; S Kruopis; A Albers; Jürgen Löffel; Andreas Neubauer; Peter Albers; Stefan Müller; Tilman Sauerbruch; T Bieber; Dieter Huhn; Ingo G H Schmidt-Wolf
Therapeutic vaccination against metastatic carcinoma by expression-modulated and immunomodified autologous tumor cells: a first clinical phase I/II trial.
Human gene therapy 2001;12(3):267-78.
2001: Peter Albers; Rüdiger Heicappell; H Schwaibold; J Wolff
Erythropoietin in urologic oncology.
European urology 2001;39(1):1-8.
2000: Marcus Rothe; Yon Ko; Peter Albers; Nicolas Wernert
Eukaryotic initiation factor 3 p110 mRNA is overexpressed in testicular seminomas.
The American journal of pathology 2000;157(5):1597-604.
2000: Rainer Souchon; Susanne Krege; HJ Schmoll; Peter Albers; Jörg Beyer; Carsten Bokemeyer; Johannes Classen; Klaus-Peter Dieckmann; Michael Hartmann; Axel Heidenreich; Wolfgang Höltl; Sabine Kliesch; Kai Uwe Köhrmann; Markus Kuczyk; Heinz Schmidberger; Stefan Weinknecht; E Winter; Christian Wittekind; D D
[Interdisciplinary consensus on diagnosis and therapy of testicular tumors. Results of an update conference based on evidence-based medicine. German Testicular Cancer study Group (GTCSG)].
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2000;176(9):388-405.
2000: Peter Albers; A Ganz; E Hannig; W D Miersch; Stefan C Müller
Salvage surgery of chemorefractory germ cell tumors with elevated tumor markers.
The Journal of urology 2000;164(2):381-4.
2000: Peter Albers; Y Ko; Eva Wardelmann; Doris Schmidt; M Adam; H Vetter; Stefan C Müller
Limitations of detection of bone-marrow micrometastasis in prostate carcinoma patients by CK18/PSA immunocytochemistry and PSA RT-PCR.
Anticancer research 2000;20(3B):2107-11.
2000: G Steiner; Erhard Bierhoff; D Schmidt; Joachim Leissner; Helmut K Wolf; Peter Albers
p53 immunoreactivity in biopsy specimens of T1G3 transitional cell carcinoma of the bladder--a helpful parameter in guiding the decision for or against cystectomy?
European journal of cancer (Oxford, England : 1990) 2000;36(5):610-4.
1999: Peter Albers; Roswitha Siener; Michael Hartmann; Stefan Weinknecht; H Schulze; U Rebmann; Markus Kuczyk; W deRiese; Volker Loy; Erhard Bierhoff; Christian Wittekind
Risk factors for relapse in stage I non-seminomatous germ-cell tumors: preliminary results of the German Multicenter Trial. German Testicular Cancer Study Group.
International journal of cancer. Journal international du cancer 1999;83(6):828-30.
1999: Peter Albers; A Göll; Erhard Bierhoff; Georg Schoeneich; Stefan C Müller
Clinical course and histopathologic risk factor assessment in patients with bilateral testicular germ cell tumors.
Urology 1999;54(4):714-8.
1999: Marcus Rothe; Peter Albers; Nicolas Wernert
Loss of heterozygosity, differentiation, and clonality in microdissected male germ cell tumours.
The Journal of pathology 1999;188(4):389-94.
1999: F von Deimling; JM Scharf; Thomas Liehr; Marcus Rothe; AR Kelter; Peter Albers; William F Dietrich; Louis Kunkel; Nicolas Wernert; Brunhilde Wirth
Human and mouse RAD17 genes: identification, localization, genomic structure and histological expression pattern in normal testis and seminoma.
Human genetics 1999;105(1-2):17-27.
1999: Peter Albers; Hans Bender; H Yilmaz; Georg Schoeneich; Hans-Jürgen Biersack; Stefan C Mueller
Positron emission tomography in the clinical staging of patients with Stage I and II testicular germ cell tumors.
Urology 1999;53(4):808-11.
1998: Peter Albers; K Dommer; Stefan C Müller
[Testicular tumors. Mortality and recurrence after inadequate therapy].
Der Urologe. Ausg. A 1998;37(6):625-8.
1998: Axel Heidenreich; M Kuczyk; Peter Albers
[Molecular pathogenesis and prognostic factors in testicular tumor].
Der Urologe. Ausg. A 1998;37(6):593-608.
1998: Jörg Thomas Hartmann; Peter Albers; C Clemm; Rainer Souchon; Lothar Weissbach; D D; C Bokemeyer
[Register study for treatment of brain metastases of malignant testicular tumors].
Der Urologe. Ausg. A 1998;37(4):426-7.
1998: W Brennemann; Birgit Stoffel-Wagner; M Wichers; A Helmers; Peter Albers; Jörg Mezger; Dietrich Klingmüller
Pretreatment follicle-stimulating hormone: a prognostic serum marker of spermatogenesis status in patients treated for germ cell cancer.
The Journal of urology 1998;159(6):1942-6.
1997: A Göll; Peter Albers; Georg Schoeneich; Gerhard Haidl; R Bürger
[Testicular loss due to hemorrhagic infarct in Tauber antegrade scrotal varicocele sclerotherapy].
Der Urologe. Ausg. A 1997;36(5):449-51.
1997: Georg Schoeneich; P Winter; Peter Albers; G Fröhlich; Stefan C Müller
Management of complete ureteral replacement. Experiences and review of the literature.
Scandinavian journal of urology and nephrology 1997;31(4):383-8.
1997: Peter Albers
[Diagnosis and therapy of testicular tumors].
Der Urologe. Ausg. A 1997;36(4):387-96.
1997: Hans Bender; AG Schomburg; Peter Albers; Jürgen Ruhlmann; Hans-Jürgen Biersack
Possible role of FDG-PET in the evaluation of urologic malignancies.
Anticancer research 1997;17(3B):1655-60.
1997: Peter Albers; Erhard Bierhoff; D Neu; Rolf Fimmers; Nicolas Wernert; Stefan C Müller
MIB-1 immunohistochemistry in clinical stage I nonseminomatous testicular germ cell tumors predicts patients at low risk for metastasis.
Cancer 1997;79(9):1710-6.
1997: Peter Albers; R A Burger; M H Braun; Jan Fichtner; Margit Fisch; M Stöckle
Automated image analysis DNA cytometry to predict the pathological stage in clinical stage I nonseminomatous testicular germ cell tumors.
European urology 1997;31(3):356-9.
1996: Peter Albers; Jan Fichtner; P Brühl; Stefan C Müller
Long-term results of internal urethrotomy.
The Journal of urology 1996;156(5):1611-4.
1996: Peter Albers; Thomas M Ulbright; J Albers; G A Miller; Attilio Orazi; W N Crabtree; J Baniel; T Reister; R A Sidner; Richard S Foster; John P Donohue
Tumor proliferative activity is predictive of pathological stage in clinical stage A nonseminomatous testicular germ cell tumors.
The Journal of urology 1996;155(2):579-86.
1995: Peter Albers; Thomas M Ulbright; J Albers; G A Miller; Richard S Foster; John P Donohue
[New parameters for prediction of pathological stage in clinical stage I non-seminomatous testicular tumors].
Der Urologe. Ausg. A 1995;34(4):316-23.
1995: Peter Albers; Attilio Orazi; Thomas M Ulbright; G A Miller; J H Haidar; John P Donohue; Richard S Foster
Prognostic significance of immunohistochemical proliferation markers (Ki-67/MIB-1 and proliferation-associated nuclear antigen), p53 protein accumulation, and neovascularization in clinical stage A nonseminomatous testicular germ cell tumors.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1995;8(5):492-7.
1995: Peter Albers; Richard S Foster; Richard Bihrle; Mark C Adams; MA Keating
Ectopic ureters and ureteroceles in adults.
Urology 1995;45(5):870-4.
1995: Peter Albers; G A Miller; Attilio Orazi; Thomas M Ulbright; J Albers; John P Donohue; Richard S Foster
Immunohistochemical assessment of tumor proliferation and volume of embryonal carcinoma identify patients with clinical stage A nonseminomatous testicular germ cell tumor at low risk for occult metastasis.
Cancer 1995;75(3):844-50.
1995: Peter Albers; W T DeRiese; Thomas M Ulbright; John P Donohue; Richard S Foster
Prognostic factors in patients with pathological stage I non-seminomatous testicular germ cell tumors and tumor recurrence during follow-up.
Urological research 1995;23(4):211-3.
1995: Peter Albers; J Albers; O W Cummings; M Boris; John P Donohue; Richard S Foster
Flow cytometric and cytophotometric DNA analysis cannot predict subsequent tumour recurrence in pathological stage IIA/B non-seminomatous testicular germ cell tumour patients who do not receive adjuvant chemotherapy.
European journal of cancer (Oxford, England : 1990) 1995;31A(5):848-9.
1994: W T de Riese; Peter Albers; E B Walker; Thomas M Ulbright; W N Crabtree; T Reister; Richard S Foster; John P Donohue
Predictive parameters of biologic behavior of early stage nonseminomatous testicular germ cell tumors.
Cancer 1994;74(4):1335-41.
1994: W T De Riese; C De Riese; Thomas M Ulbright; E B Walker; J Messemer; J A Jones; T Reister; Peter Albers; E P Allhoff; Richard S Foster
Flow-cytometric and quantitative histologic parameters as prognostic indicators for occult retroperitoneal disease in clinical-stage-I non-seminomatous testicular germ-cell tumors.
International journal of cancer. Journal international du cancer 1994;57(5):628-33.
1994: Peter Albers; W deRiese; E B Walker; Thomas M Ulbright; W N Crabtree; T Reister; Richard S Foster; John P Donohue
Predictive parameters in biologic assessment of low-stage retroperitoneal lymph-node dissection.
World journal of urology 1994;12(3):120-4.